Search for content, post, videos

Latest news

Sponsored content


In Focus – Entrepreneurs


New Innovation and Design

Clinical Trials

Promising results from NeuroVive
Promising results from NeuroVive

NeuroVive Pharmaceutical and Yungjin Pharm announces that the phase I clinical study in Korea within the companies’ joint project KL1333, an investigational treatment for genetic mitochondrial disorders, including MELAS (Mitochondrial

Drug Development

Careers – On A New Job

View our latest newsletter